619 related articles for article (PubMed ID: 21979811)
21. Induced circular dichroism spectra reveal binding of the antiinflammatory curcumin to human alpha1-acid glycoprotein.
Zsila F; Bikádi Z; Simonyi M
Bioorg Med Chem; 2004 Jun; 12(12):3239-45. PubMed ID: 15158792
[TBL] [Abstract][Full Text] [Related]
22. Curcumin: a pleiotropic phytonutrient in diabetic complications.
Jeenger MK; Shrivastava S; Yerra VG; Naidu VG; Ramakrishna S; Kumar A
Nutrition; 2015 Feb; 31(2):276-82. PubMed ID: 25441584
[TBL] [Abstract][Full Text] [Related]
23. Novel curcumin-based pyrano[2,3-d]pyrimidine anti-oxidant inhibitors for α-amylase and α-glucosidase: Implications for their pleiotropic effects against diabetes complications.
Yousefi A; Yousefi R; Panahi F; Sarikhani S; Zolghadr AR; Bahaoddini A; Khalafi-Nezhad A
Int J Biol Macromol; 2015; 78():46-55. PubMed ID: 25843662
[TBL] [Abstract][Full Text] [Related]
24. Multi-spectroscopic analysis and molecular modeling on the interaction of curcumin and its derivatives with human serum albumin: a comparative study.
Ge YS; Jin C; Song Z; Zhang JQ; Jiang FL; Liu Y
Spectrochim Acta A Mol Biomol Spectrosc; 2014 Apr; 124():265-76. PubMed ID: 24491667
[TBL] [Abstract][Full Text] [Related]
25. Bisdemethylcurcumin and structurally related hispolon analogues of curcumin exhibit enhanced prooxidant, anti-proliferative and anti-inflammatory activities in vitro.
Ravindran J; Subbaraju GV; Ramani MV; Sung B; Aggarwal BB
Biochem Pharmacol; 2010 Jun; 79(11):1658-66. PubMed ID: 20138025
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of curcumin acetates and amino acid conjugates as proteasome inhibitors.
Wan SB; Yang H; Zhou Z; Cui QC; Chen D; Kanwar J; Mohammad I; Dou QP; Chan TH
Int J Mol Med; 2010 Oct; 26(4):447-55. PubMed ID: 20818481
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological properties and underlying mechanisms of curcumin and prospects in medicinal potential.
Fu YS; Chen TH; Weng L; Huang L; Lai D; Weng CF
Biomed Pharmacother; 2021 Sep; 141():111888. PubMed ID: 34237598
[TBL] [Abstract][Full Text] [Related]
28. Curcumin analogues and derivatives with anti-proliferative and anti-inflammatory activity: Structural characteristics and molecular targets.
Chainoglou E; Hadjipavlou-Litina D
Expert Opin Drug Discov; 2019 Aug; 14(8):821-842. PubMed ID: 31094233
[No Abstract] [Full Text] [Related]
29. Inhibition of LPS-induced production of inflammatory factors in the macrophages by mono-carbonyl analogues of curcumin.
Liang G; Zhou H; Wang Y; Gurley EC; Feng B; Chen L; Xiao J; Yang S; Li X
J Cell Mol Med; 2009 Sep; 13(9B):3370-9. PubMed ID: 19243473
[TBL] [Abstract][Full Text] [Related]
30. Curcumin-free turmeric exhibits anti-inflammatory and anticancer activities: Identification of novel components of turmeric.
Aggarwal BB; Yuan W; Li S; Gupta SC
Mol Nutr Food Res; 2013 Sep; 57(9):1529-42. PubMed ID: 23847105
[TBL] [Abstract][Full Text] [Related]
31. Interaction of curcumin with β-lactoglobulin-stability, spectroscopic analysis, and molecular modeling of the complex.
Sneharani AH; Karakkat JV; Singh SA; Rao AG
J Agric Food Chem; 2010 Oct; 58(20):11130-9. PubMed ID: 20925386
[TBL] [Abstract][Full Text] [Related]
32. Probing the binding site of curcumin in Escherichia coli and Bacillus subtilis FtsZ--a structural insight to unveil antibacterial activity of curcumin.
Kaur S; Modi NH; Panda D; Roy N
Eur J Med Chem; 2010 Sep; 45(9):4209-14. PubMed ID: 20615583
[TBL] [Abstract][Full Text] [Related]
33. A simplified curcumin targets the membrane of Bacillus subtilis.
Morão LG; Polaquini CR; Kopacz M; Torrezan GS; Ayusso GM; Dilarri G; Cavalca LB; Zielińska A; Scheffers DJ; Regasini LO; Ferreira H
Microbiologyopen; 2019 Apr; 8(4):e00683. PubMed ID: 30051597
[TBL] [Abstract][Full Text] [Related]
34. Cyclocurcumin as Promising Bioactive Natural Compound: An Overview.
Gasbarri C; Angelini G
Molecules; 2024 Mar; 29(7):. PubMed ID: 38611731
[TBL] [Abstract][Full Text] [Related]
35. Targeted therapies of curcumin focus on its therapeutic benefits in cancers and human health: Molecular signaling pathway-based approaches and future perspectives.
Islam MR; Rauf A; Akash S; Trisha SI; Nasim AH; Akter M; Dhar PS; Ogaly HA; Hemeg HA; Wilairatana P; Thiruvengadam M
Biomed Pharmacother; 2024 Jan; 170():116034. PubMed ID: 38141282
[TBL] [Abstract][Full Text] [Related]
36. Synthetic and Medicinal Prospective of Structurally Modified Curcumins.
Kumar B; Singh V; Shankar R; Kumar K; Rawal RK
Curr Top Med Chem; 2017; 17(2):148-161. PubMed ID: 27280465
[TBL] [Abstract][Full Text] [Related]
37. Curcumin: therapeutical potential in ophthalmology.
Pescosolido N; Giannotti R; Plateroti AM; Pascarella A; Nebbioso M
Planta Med; 2014 Mar; 80(4):249-54. PubMed ID: 24323538
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic Applications of Curcumin Nanoformulations.
Yallapu MM; Nagesh PK; Jaggi M; Chauhan SC
AAPS J; 2015 Nov; 17(6):1341-56. PubMed ID: 26335307
[TBL] [Abstract][Full Text] [Related]
39. Diketo modification of curcumin affects its interaction with human serum albumin.
Shaikh SAM; Singh BG; Barik A; Ramani MV; Balaji NV; Subbaraju GV; Naik DB; Indira Priyadarsini K
Spectrochim Acta A Mol Biomol Spectrosc; 2018 Jun; 199():394-402. PubMed ID: 29635184
[TBL] [Abstract][Full Text] [Related]
40. Determining the effects of lipophilic drugs on membrane structure by solid-state NMR spectroscopy: the case of the antioxidant curcumin.
Barry J; Fritz M; Brender JR; Smith PE; Lee DK; Ramamoorthy A
J Am Chem Soc; 2009 Apr; 131(12):4490-8. PubMed ID: 19256547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
